Healthcare communications group inVentiv Health has locked up backing from private equity firm Advent International in a deal that values the company at $3.8B.
Advent joins inVentiv's existing private equity owner, Thomas H. Lee Partners, as equal owner of the parent company to PR firms like Chandler Chicco Agency and Allidura Consumer.
"This will allow us to realize our full potential so we can better serve the biopharmaceutical industry in navigating an increasingly complex scientific and regulatory environment," said inVentiv chairman and CEO Michael Bell (pictured).
The investment means that inVentiv's plans for an initial public offering, filed in April, will be scrapped "at this time," the company said.
Abernathy MacGregor repped Advent on the PR front, whiel Sard Verbinnen & Co. advised inVentiv and Thomas H. Lee in the deal, which is expected to close in the fourth quarter.
Joele Frank handles Crinetics Pharmaceuticals as the specialist for treatments for endocrine diseases agrees to get acquired by Vertex Pharmaceuticals in a deal pegged at $8.8B.
Teneo represents Honeywell spin-off Solstice Advanced Materials as it buys Collected Strategies client Element Solutions in a deal pegged at $14.5B.
Dallas-based Throughline Global Advisors advised Principal Mineral as it acquired Isola Group, maker of copper-clad laminates used in printed circuit boards.
oele Frank works for satellite operator Iridium Communications as it gets acquired by space company Rocket Lab in a deal worth $8B.
Uber’s Mike Lucarelli is moving to NXP Semiconductors as senior VP-investor relations.
